news

March 26, 2020

Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus’s Epidemiology

Two teams of infectious disease researchers in Italy say they have further analyzed the SARS-CoV-2 genome from samples acquired locally to generate early data... Read More
March 12, 2020

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) for Patients with Hepatocellular Carcinoma (HCC) Previously Treated with Sorafenib

-Bristol Myers Squibb Company (NYSE: BMY) today announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved... Read More
March 12, 2020

Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design... Read More
March 12, 2020

Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer

Thermo Fisher Scientific announced today it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson,... Read More
March 12, 2020

Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, has announced it has entered into definitive agreements to acquire YouScript, a privately held clinical... Read More
March 3, 2020

Thermo Fisher Scientific to Acquire QIAGEN N.V

WALTHAM, Mass. and VENLO, The Netherlands – March 3, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and... Read More
February 13, 2020

Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research

Thermo Fisher Scientific has introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of... Read More
February 4, 2020

Bicameral, Bipartisan Group of Lawmakers Form Congressional Personalized Medicine Caucus

The Personalized Medicine Coalition (PMC) today announces its support for a new bicameral, bipartisan Congressional Personalized Medicine Caucus formed by Sens. Tim Scott (R-SC)... Read More
January 22, 2020

Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant

Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs... Read More
January 22, 2020

Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity... Read More
January 15, 2020

LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development

LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion... Read More
January 14, 2020

Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch

Dr. Thomas J. Lynch Jr. will become Fred Hutchinson Cancer Research Center’s new president and director, the organization announced today. Lynch, a well-known cancer... Read More
January 13, 2020

Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts

Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization)... Read More
January 13, 2020

Roche and Illumina partner to broaden patient access to genomic testing

Roche has announced that it has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based... Read More
December 12, 2019

Michael Rivers, Head of Roche Digital Pathology, named president of Digital Pathology Association

Michael Rivers, Vice President, Roche Digital Pathology, has been named president of the Digital Pathology Association (DPA), effective Jan. 1, 2020. The DPA is... Read More
MORE NEWS